1.
Two On-Label Injection Volumes of AbobotulinumtoxinA (ABO) Produce Simlar Safety and Efficacy Results when Used to Treate Moderate to Sever Glabellar Lines. J of Skin [Internet]. 2017 Oct. 27 [cited 2025 Apr. 19];1(3.1):s91. Available from: https://skin.dermsquared.com/skin/article/view/142